what skin glutathione for the Glutathione Skin Brightener™ with Ceramosides®
Description
V.FisherR
These preclinical findings support its potential as a powerful addition to AML therapy, particularly in resistant and high-risk patient subgroups
The reactive metabolites generated after drug biotransformation can covalently bind to cellular proteins, lipids, and nucleic acids, leading to triggering immune responses and cellular damage (Fig
(March 2005)
